Bristol-Myers Squibb Company

BMY

(NYSE)

$ 43,30
Opdateret 06:05:27

Idag

Market closed

Marked er lukket, åbner klokken 15:30

	16 maj	Pair of Studies Show Power of Immune System to Fight Cancer

	06 maj	U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

	06 maj	Bristol-Myers, AstraZeneca: Study Shows Metreleptin May Treat Pediatric Lipodystrophy

	01 maj	3rd UPDATE: Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity

	01 maj	2nd UPDATE: Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity

	01 maj	UPDATE: Vertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down

	30 apr	Vertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down

	29 apr	Merck and Pfizer Agree to Develop Type 2 Diabetes Treatment

	25 apr	2nd UPDATE: Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales

	25 apr	UPDATE: Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales

Konsensusmål

38,50 USD

P/E (2013E)

23,6x

K/I (2013E)

5,26x

Direkte afkast (2013E)

3,3%

Konsensus anbefaling

Sælg

Hold

Køb

Åbn analyse

Kilde: FactSet Research

Ingen beskrivelse

For lav Flash Player version